Low Dose Exposure to Carcinogens and Metabolic Gene Polymorphisms

  • Emanuela Taioli
  • Seymour Garte
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 472)


Metabolic gene polymorphisms encode for enzymes which are involved in both metabolism and conjugation of environmental as well endogenous compounds. Some of the products of the metabolic process are carcinogens. Two main categories of metabolic genes are known: Phase I genes, which include CYP1A1, CYP2E1, CYP2D6, and Phase II genes, such as GSTM1, GSTT1, NAT2. Polymorphisms have been described in these genes, with different frequencies according to ethnicity and geographic area.1 Several case-control studies have been conducted to study the association between metabolic gene polymorphisms and cancer of various sites, with special focus on lung and bladder cancer. It has been suggested that these genes play a role in cancer risk only when they interact with environmental exposure, since the substrates of their gene products are xenobiotic chemicals or their metabolites.2 This form of gene-environment interaction (GEI) has been described as “Type 2” GEI by Khoury3 and Ottman.4 According to this model, the presence or absence of the genetic risk factor is irrelevant for disease causation, if there is no exposure to an environmental agent. When the dose of environmental exposure (such as smoking) is analyzed with respect to metabolic susceptibility gene polymorphisms, two patterns are seen. In one case, a low exposure-gene (LEG) effect is observed, in which a decreasing degree of interaction occurs as a function of increasing exposure dose. A high exposure-gene (HEG) effect is observed when there is an increased degree of interaction as a function of exposure dose.2


Genetic Risk Factor Lung Cancer Risk Sister Chromatid Exchange GSTM1 Null Genotype GSTM1 Genotype 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Garte S.J., Trachman J., Crofts E, Taioli E., Toniolo P., Buxbaum J., and Bayo S. CYP1A1 genotypes in African-Americans and Caucasians. Human Heredity 46, 121–127, 1996.PubMedCrossRefGoogle Scholar
  2. 2.
    Taioli E., Zocchetti C., and Garte S.J. Models of interaction between metabolic genes and environmental exposure in cancer susceptibility. Environm. Health Persp. 106, 67–70, 1998.CrossRefGoogle Scholar
  3. 3.
    Khoury M.J. and James L.M. Population and familial relative risks of disease associated with environmental factors in the presence of gene-environment interaction. Am J Epidemiol. 137, 1241–50, 1993.PubMedGoogle Scholar
  4. 4.
    Ottman R. An epidemiologic approach to gene-environment interaction. Genet. Epidemiol. 7, 177–185, 1990.PubMedCrossRefGoogle Scholar
  5. London S.J., Daly A.K., Cooper J., Navidi W.C., Carpenter C.L., and Idle J.R. Polymorphism of glutathione S-transferase Ml and lung cancer risk among African-Americans and Caucasians in Los Angeles county, California. JNCI, 87, 1246–1253,1995.Google Scholar
  6. 6.
    Kihara M., Noda K., and Kihara M. Distribution of GSTM1 null genotype in relation to gender, age, and smoking status in Japanese lung cancer patients. Pharmacogenetics 5, S74 - S79, 1995.PubMedCrossRefGoogle Scholar
  7. 7.
    Brockmoller J., Kerb R., Drakoulis N., Nitz M., and Roots I. Genotype of glutatione S-transferase class µ isoenzymes t and `P in lung cancer patients and controls. Cancer Research, 53, 1004–1011, 1993.PubMedGoogle Scholar
  8. 8.
    Nakachi K., Imai K., Hayashi S., Wtanabe J., and Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Research, 51, 5177–5180, 1991.PubMedGoogle Scholar
  9. 9.
    Sugimura H. Suzuki I. Hamada G.S., Iwase T., Takahashi T., Nagura K., Iwata H. Watanabe S., Kino I. and Tsugane S. Cytochrome P-450 1A1 genotype in lung cancer patients and controls in Rio de Janeiro, Brazil. Cancer Epidem Biom Prey, 3,145–148,1994.Google Scholar
  10. 10.
    London S.J., Daly A.K., and Fairbrother K.S. Lung cancer risk in African-Americans in relation to a race-specific CYP1A1 polymorphism. Cancer Research, 55, 6035–6037, 1995.PubMedGoogle Scholar
  11. 11.
    Taioli E., Crofts E, Trachman J., Demopoulos R., and Garte SJ. A specific African-American polymorphism is associated with adenocarcinoma of the lung. Cancer Research, 55, 472–73, 1995.PubMedGoogle Scholar
  12. 12.
    Taioli E., Ford J., Trachman J., Li Y., Demopoulos R. and Garte S. Lung cancer risk and CYP1A1 genotype in African-Americans. Carcinogenesis, 19: 813–18, 1998.PubMedCrossRefGoogle Scholar
  13. 13.
    Kelsey K.T., Wiencke J.K., and Spitz M.R. A race-specific genetic polymorphismin the CYP1A1 gene is not associated with lung cancer in African-Americans. Carcinogenesis 15, 1121–1124, 1994.PubMedCrossRefGoogle Scholar
  14. 14.
    Nakachi K., Imai K., Hayashi S., and Kawajiri K. Polymorphisms of the CYP1A1 and glutathione Stransferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Research, 53, 2994–2999, 1993.PubMedGoogle Scholar
  15. 15.
    Kihara M., Kihara M., and Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis, 16, 2331–2336, 1995.PubMedCrossRefGoogle Scholar
  16. 16.
    Bernardini S., Hirvonen A., Pelin K., and Norppa H. Induction of sister chromatid exchange by 1,2- epoxy-3-butene in cultured human lymphocytes: influence of GSTT1 genotype. Carcinogenesis, 19, 377–80, 1998.PubMedCrossRefGoogle Scholar
  17. 17.
    Uuskula M., Jarventaus H., Hirvonen A., Orsa M., and Norppa H. Influence of GSTM1 genotype on sister chromatid exchange induction by styrene-7,8-oxide and 1,2-epoxy-3-butene in cultured human lymphocytes. Carcinogenesis, 16, 947–50, 1995.PubMedCrossRefGoogle Scholar
  18. 18.
    Norppa H., Hirvonen A., Jarventaus H., Uuskula M.,Tasa G., Ojajarvi A., and Sorsa M. Role of GSTTl and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes. Carcinogenesis, 16, 1261–64, 1995.PubMedCrossRefGoogle Scholar
  19. 19.
    Merlo F, Andreassen A., Weston A., Pan C.-F., Haugen A., Valerio E, Reggiardo G., Fontana V., Garte S., Puntoni R., and Abbondandolo A. Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of plycyclic aromatic hydrocarbons. Cancer Epidemiol Biomark Prevent, 7, 147–155, 1998.Google Scholar
  20. 20.
    Vineis P. Molecular epidemiology: low-dose carcinogens and genetic susceptibility. Int. J. Cancer, 71, 1–3, 1997.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Emanuela Taioli
    • 1
  • Seymour Garte
    • 2
  1. 1.Policlinico IRCCS, University of MilanMilanItaly
  2. 2.EOHSI, UMDNJ-Robert Wood Johnson Medical SchoolPiscatawayUSA

Personalised recommendations